Table 4.
Dependent variable | Predictor | β | P |
---|---|---|---|
Overall group using Vitamin D doses groups a | |||
A, SBP | Vitamin D doses group (reference low) | .689 | .682 |
Age | .232 | .121 | |
Sex, reference male | −1.903 | .200 | |
BMI | .294 | .055 | |
Baseline SBP | .160 | <.0001 | |
Change in HTN medication*(reference no medication) | .724 | .564 | |
Time | −.518 | .724 | |
Time#Arm interaction | −.197 | .924 | |
B, DBP | Vitamin D doses group (reference low) | .337 | .762 |
Age | .142 | .149 | |
Sex, female vs male | −2.640 | .008 | |
BMI | .280 | .007 | |
Baseline DBP | .238 | <.0001 | |
Change in HTN medication*(reference no medication) | −.411 | .622 | |
Time | −.429 | .661 | |
Time#Arm interaction | −.553 | .690 |
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HTN, hypertension; SBP, systolic blood pressure.
* No change or change in dose or number of hypertension medications.
# Interaction.
a Model was adjusted for vitamin doses group, age, sex, BMI at 6 and 12 months, baseline SBP/DBP, no change or change in dose or number of hypertension medications, time, and included an interaction between vitamin doses group and time.